According to previous studies, colorectal tumors characterized by high ZEB2, EMT, stem cell traits and low proliferative index are more likely to belong to the CMS4 consensus molecular subtype of CRC (7, 42). This evidence concerns the gene ZEB2 and colorectal carcinoma.